Cargando…
1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial.
BACKGROUND: Pulse glucocorticoid therapy is used in COVID-19 infection. We evaluated the effectiveness of methylprednisolone 250 mg/d for 3 days vs. dexamethasone 6 mg/d for 10 days in patients with severe but not critical COVID-19 pneumonia. METHODS: A multicentre, randomized, open-label, controlle...
Autores principales: | Gutierrez, Carlos Dueñas, Abadia-Otero, Jesica, Cusacovich, Ivan, Martín-González, Jose Ignacio, Muela-Molinero, Alberto, Corral-Gudino, Luis, González-Fuentes, Roberto, de Temiño, Ängela Ruíz, Moral, Elena Tapia, Cuadrado-Medina, Francisca, Martín-Asenjo, Miguel, Gonzalez, Pablo Miramontes, Delgado Morales, Jose Luis, Ines, Sandra, Abad-Manteca, Laura, Usategui-Martín, Iciar, Ruíz-Albí, Tomás, Miranda-Riaño, Sara, Rodríguez-Fortúnez, Patricia, Rodríguez-Jiménez, Consuelo, López-Franco, Esperanza, Marcos, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752252/ http://dx.doi.org/10.1093/ofid/ofac492.964 |
Ejemplares similares
-
Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial
por: Najafi, Safa, et al.
Publicado: (2023) -
Central Precocious Puberty: Treatment with Triptorelin 11.25 mg
por: Chiocca, Elena, et al.
Publicado: (2012) -
Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
por: Leo, Angelo Di, et al.
Publicado: (2013) -
Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study
por: Yang, Jianmei, et al.
Publicado: (2022) -
Cuestiones por resolver en el tratamiento con glucocorticoides de la infección COVID-19
por: Corral-Gudino, Luis, et al.
Publicado: (2021)